Login

Financial Snapshot

Revenue
TTM
$1.496M
Gross Margin
TTM
20.34%
Net Income
TTM
-$31.36M
Current Assets
2024 Q2
Current Liabilities
2024 Q2
Current Ratio
2024 Q2
2.01%
Total Assets
2024 Q2
Total Liabilities
2024 Q2
Book Value
2024 Q2
-$37.23M
Cash
2024 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$3.733M

Stock Price

Loading...
Market Cap: $149.52 Thousand

About PRESSURE BIOSCIENCES INC

Pressure BioSciences, Inc. engages in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. The company is headquartered in Canton, Massachusetts and currently employs 15 full-time employees. Its products/services are based on three high-pressure platforms: Ultra Shear Technology (UST), BaroFold Technology (BaroFold), and Pressure Cycling Technology (PCT). The UST platform allows for the creation of stable nanoemulsions of otherwise immiscible oil-based active components in water. The company also allows for the preparation of higher quality, homogenized, extended shelf-life or room temperature-stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. PCT utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. The BaroFold platform provides valuable contract services and GMP manufacturing equipment to the biopharmaceutical industry.

Industry: Laboratory Analytical Instruments Peers: BNB Plus Corp Rivulet Media, Inc. Telesis Bio Inc. Reflect Scientific Inc RADNOSTIX INC IsoPlexis Corp Miromatrix Medical Inc. Atlantic International Corp Thermo Fisher Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support